cycloastragenol has been researched along with Ischemic Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Gao, X; Li, S; Li, Z; Shu, S; Wang, Z; Zou, Y | 1 |
1 other study(ies) available for cycloastragenol and Ischemic Stroke
| Article | Year |
|---|---|
Cycloastragenol suppresses M1 and promotes M2 polarization in LPS-stimulated BV-2 cells and ischemic stroke mice.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Ischemic Stroke; Lipopolysaccharides; Mice; Microglia; NF-E2-Related Factor 2; NF-kappa B; Sapogenins | 2022 |